The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: A general view of antibacterial susceptibility

Journal of Infection and Chemotherapy

Volumn 14, Issue 4, 2008, Pages 279-290

  Niki, Y ^a   Hanaki, H ^b   Yagisawa, M ^b   Kohno, S ^b,ah   Aoki, N ^b,t   Watanabe, A ^b   Sato, J ^b   Hattori, R ^b   Koashi, N ^b   Kozuki, T ^b   Maruo, A ^b   Morita, K ^b   Ogasawara, K ^b   Takahashi, Y ^b   Watanabe, J ^b   Takeuchi, K ^c   Takahashi, M ^c   Takeda, H ^d   Ikeda, H ^e   Kaneda, H ^e   Niitsuma, K ^f   Saito, M ^f   Koshiba, S ^f   Kaneko, M ^f   Itabashi, S ^g   Miki, M ^h   Nakanowatari, S ^h   Honda, Y ⁱ   Chiba, J ⁱ   Takahashi, H ^j   Utagawa, M ^j   Kondo, T ^k   Kawana, A ^k   Konosaki, H ^k   Aoki, Y ^l,ae   Chonabayashi, N ^m   Ueda, H ^m   Sugiura, H ^m   Ichioka, M ⁿ   Goto, H ^o   Aoshima, M ^o   Okazaki, M ^o   Ozawa, T ^p   Horiuchi, F ^p   Yoshida, T ^q   Tsukada, H ^r   Kobayashi, S ^r   Yoshikawa, H ^s   Imai, Y ^s   Honma, Y ^t   Yoshida, K ^u   Takaya, M ^u   Kurokawa, Y ^u   Kuwabara, M ^v   Fujiue, Y ^v   Ishimaru, T ^w   Matsubara, N ^w   Kawasaki, Y ^x   Tokuyasu, H ^x   Masui, K ^x   Shimizu, E ^y   Yoneda, K ^y   Negayama, K ^z   Ueda, N ^aa   Ishimaru, M ^aa   Nakanishi, Y ^ab   Fujita, M ^ab   Honda, J ^ac   Kadota, J ^ad   Hiramatsu, K ^ad   Nagasawa, Z ^af   Suga, M ^ag   Muranaka, H ^ag   Yanagihara, K ^ah   Fujita, J ^ai   Tateyama, M ^ai   Totsuka, K ^b   more..

^a JSC Surveillance Committee   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c Iwate Prefectural Central Hospital   (Japan)

^d Yamagata Saisei Hospital   (Japan)

^e Sanyudo Hospital   (Japan)

^f Central Aizu General Hospital   (Japan)

^g South Miyagi Medical Center   (Japan)

^h JAPANESE RED CROSS SOCIETY   (Japan)

ⁱ SENDAI KOUSEI HOSPITAL   (Japan)

^j Saka General Hospital   (Japan)

^k NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^m ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

ⁿ Toshima Tokyo Metropolitan Hospital   (Japan)

^o KYORIN UNIVERSITY   (Japan)

^p Yamanashi Red Cross Hospital   (Japan)

^q TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^r NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^s NIIGATA CITY GENERAL HOSPITAL   (Japan)

^t Shinrakuen Hospital   (Japan)

^u KAWASAKI MEDICAL SCHOOL   (Japan)

^v HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^w Shimonoseki City Hospital   (Japan)

^x MATSUE RED CROSS HOSPITAL   (Japan)

^y TOTTORI UNIVERSITY HOSPITAL   (Japan)

^z KAGAWA UNIVERSITY   (Japan)

^aa EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^ab KYUSHU UNIVERSITY   (Japan)

^ac KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ad OITA UNIVERSITY   (Japan)

^ae SAGA UNIVERSITY   (Japan)

^af SAGA UNIVERSITY HOSPITAL   (Japan)

^ag SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^ah NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ai UNIVERSITY OF THE RYUKYUS   (Japan)

more..

Author keywords

Drug; Resistance; Respiratory tract infection; Surveillance; Susceptibility

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFACLOR; CEFAZOLIN; CEFCAPENE; CEFDINIR; CEFDITOREN; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GLYCOPEPTIDE; KETOLIDE; LINCOSAMIDE; MACROLIDE; METICILLIN; OXACILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL LABORATORY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 50049127965     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0623-2     Document Type: Article

References (14)

1. The Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults 2000 (in Japanese). Tokyo: The Japanese Respiratory Society; 2000.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement M100-S16 and M45-P. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed. Document M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
3. H. Hanaki R. Kubo T. Nakano M. Kurihara K. Sunagawa 2004 Characterization of HMRZ-86: a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases J Antimicrob Chemother 53 888 889
4. R. Colodner B. Reznik V. Gal H. Yamazaki H. Hanaki R. Kubo 2006 Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases Eur J Clin Microbiol Infect Dis 25 49 51
5. S.G. Jenkins D.J. Farrell M. Patel B.S. Lavin 2005 Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3 J Infect 51 355 363
6. K. Barada H. Hanaki S. Ikeda Y. Yamaguchi H. Akama T. Nakae 2007 Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes J Infect Chemother 13 74 78
7. T. Mochizuki N. Okamoto T. Yagishita K. Takuhiro K. Mashiko F. Ogawa 2004 Analysis of antimicrobial drug resistance of Staphylococcus aureus strains by WHONET 5: microbiology laboratory database software J Nippon Med Sch 71 345 351
8. K. Hiramatsu H. Hanaki T. Ino K. Yabuta T. Oguri F.C. Tenover 1997 Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J Antimicrob Chemother 40 135 136
9. H. Hanaki Y. Hososaka C. Yanagisawa Y. Otsuka Z. Nagasawa T. Nakae 2007 Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan J Infect Chemother 13 118 121
10. H. Kamiya T. Kato T. Togashi S. Iwata T. Kurosaki S. Baba 2007 The Research Group on Streptococcus pneumoniae Serotypes among Children. Epidemiological survey of Pneumococcus serotypes in pediatric patients with acute suppurative otitis media (in Japanese; abstract in English) Kansenshogaku Zasshi 81 59 66
11. N. Chiba R. Kobayashi K. Hasegawa M. Morozumi E. Nakayama T. Tajima 2005 Acute Respiratory Diseases Study Group. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children J Antimicrob Chemother 56 756 760
12. A. James J.A. Karlowsky C. Thornsberry I.A. Critchley M.E. Jones A.T. Evangelista 2003 Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST Studies in the United States Antimicrob Agents Chemother 47 1790 1797
13. K. Hasegawa R. Kobayashi E. Takada A. Ono N. Chiba M. Morozumi 2006 Nationwide Surveillance for Bacterial Meningitis. High prevalence of type b beta-lactamase-non-producing ampicillinresistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced J Antimicrob Chemother 57 1077 1082
14. T. Muratani T. Matsumoto 2006 Urinary tract infection caused by fluoroquinolone-and cephem-resistant Enterobacteriaceae Int J Antimicrob Agents 28 Suppl1 10 13